Appraisals - ASAR & FAR

09/08/2019

Final Recommendation: rilpivirine (Edurant) 557

23/02/2022

Final Recommendation: ravulizumab (Ultomiris) 4869

07/11/2022

Final recommendation: ambrisentan (Volibris) 4819

07/11/2022

Final Recommendation: ferric maltol (Feraccru) 5116

09/08/2019

Final Recommendation: atorvastatin (Lipitor) 1480

09/08/2019

Final Recommendation: argatroban (Exembol) 1405

08/08/2019

Final Recommendation: aclidinium bromide (Eklira Genuair) 938

27/09/2022

Final Recommendation: dupilumab (Dupixent) 4017

17/06/2022

Final Recommendation: bevacizumab (Avastin) 5044

27/09/2022

Final Recommendation: rituximab (MabThera) 3192

27/09/2022

Final Recommendation: lacosamide (Vimpat) 4698

27/09/2022

Final Recommendation: insulin degludec (Tresiba) 5196

27/09/2022

Final Recommendation: hydrocortisone (Efmody) 3017

26/06/2019

Final Recommendation: dasatinib (Sprycel) 1514

30/11/2020

Final Recommendation: eslicarbazepine acetate (Zebinix) 1214

30/11/2020

Final Recommendation: rufinamide (Inovelon) 991

26/06/2019

Final Recommendation: blinatumomab (Blincyto) 3769

27/06/2019

Final Recommendation: mepolizumab (Nucala) 3750

26/06/2019

Final Recommendation: ataluren (Translarna) 3911

26/06/2019

Final Recommendation: romiplostim (Nplate) 3103